Schroeder Thilo's Form 4 filing
PMV Pharmaceuticals, Inc. (PMVP) · filed Sep 29, 2021
- Accession no.
- 0001209191-21-058091
- Filed
- Sep 29, 2021
- Trade date
- Sep 27-29, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $224.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schroeder ThiloCIK 0001776412 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 27, 2021 | Common Stock | SSaleDisposed | −1,753 | $30.11 | −$52,782.83 | 1,122,410 | Indirect | |
| Sep 29, 2021 | Common Stock | SSaleDisposed | −5,708 | $30.04 | −$171,468.32 | 1,116,702 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.